About 1 result found for searched term "CLZ-8 " (0.542 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M30471 | CLZ-8 | Bcl-2 |
| CLZ-8 (Compound 8) is an orally active Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. CLZ-8 exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
